Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Carpenter

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Cancer|April 15, 2009
Beyond toxicity: the challenge and importance of understanding the full impact of treatment decisionsWilliam R Carpenter, Jeffrey Peppercorn
Journal of Clinical Epidemiology|January 9, 2007
Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptomsPaul A Godley, William R Carpenter
Missouri Medicine|February 8, 2021
The Missouri Physician and Health Professional Wellness Program: A Comprehensive Resource for Physician WellnessWilliam R Carpenter, James Wieberg, Heather Johns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2013
Reply to H. Wong et alHanna K Sanoff, William R Carpenter, Til Stürmer
Journal of the National Cancer Institute|January 31, 2008
Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancerWilliam R Carpenter, Whitney R Robinson, Paul A Godley
Cancer Control : Journal of the Moffitt Cancer Center|November 1, 2006
Building community capacity to participate in cancer prevention researchMartha M McKinney, Bryan J Weiner, William R Carpenter
Annals of Translational Medicine|April 1, 2017
Next steps to improve disparities in lung cancer treatment clinical trial enrollmentLeah L Zullig, William R Carpenter, Christina D Williams
Cancer|December 8, 2005
Adapting clinical trials networks to promote cancer prevention and control researchBryan J Weiner, Martha M McKinney, William R Carpenter
Medical Care|April 12, 2011
Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapySuja S Rajan, Gary H Lyman, Sally C Stearns, et al.
Breast Cancer Research and Treatment|May 18, 2011
Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patientsSuja S Rajan, Sally C Stearns, Gary H Lyman, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Cancer|April 15, 2009
Beyond toxicity: the challenge and importance of understanding the full impact of treatment decisionsWilliam R Carpenter, Jeffrey Peppercorn
Journal of Clinical Epidemiology|January 9, 2007
Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptomsPaul A Godley, William R Carpenter
Missouri Medicine|February 8, 2021
The Missouri Physician and Health Professional Wellness Program: A Comprehensive Resource for Physician WellnessWilliam R Carpenter, James Wieberg, Heather Johns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2013
Reply to H. Wong et alHanna K Sanoff, William R Carpenter, Til Stürmer
Journal of the National Cancer Institute|January 31, 2008
Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancerWilliam R Carpenter, Whitney R Robinson, Paul A Godley
Cancer Control : Journal of the Moffitt Cancer Center|November 1, 2006
Building community capacity to participate in cancer prevention researchMartha M McKinney, Bryan J Weiner, William R Carpenter
Annals of Translational Medicine|April 1, 2017
Next steps to improve disparities in lung cancer treatment clinical trial enrollmentLeah L Zullig, William R Carpenter, Christina D Williams
Cancer|December 8, 2005
Adapting clinical trials networks to promote cancer prevention and control researchBryan J Weiner, Martha M McKinney, William R Carpenter
Medical Care|April 12, 2011
Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapySuja S Rajan, Gary H Lyman, Sally C Stearns, et al.
Breast Cancer Research and Treatment|May 18, 2011
Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patientsSuja S Rajan, Sally C Stearns, Gary H Lyman, et al.
Pageof 9